Where did the money from the Paycheck Protection Program (PPP) go?

Where did the money from the Paycheck Protection Program (PPP) go?

That is the question answered in a paper by Autor et al. (2022). Some background on PPP:

Congress enacted the Paycheck Protection Program (PPP), which provided uncollateralized, low-interest loans of up to $10 million to firms with fewer than 500 employees—loans that were forgivable on the condition that recipient firms maintained employment and wages at close to pre-crisis levels in the two to six months following loan receipt.

PPP was one for three large federal initiatives to combat the impact of COVID-19 on the US economy. These three (and relevant funding) include:

  • Paycheck Protection Program: $800 billion
  • Stimulus checks: $800 billion
  • Unemployment benefits: $680 billion

Note that each of these 3 programs was approximately the same size as the American Recovery and Reinvestment Act of 2009 (ARRA), the main fiscal stimulus passed in response to the 2007-2009 Great Recession.

What was the impact of PPP? The authors found that it:

meaningfully blunted pandemic job losses, preserving somewhere between 1.98 and 3.0 million job-years of employment during and after the pandemic at a substantial cost of $169,000 to $258,000 per job-year saved. PPP also reduced the rate of temporary closures among small firms, though it is less clear whether it reduced permanent closures. The majority of PPP loan dollars issued in 2020—66 to 77 percent— did not go to paychecks, however, but instead accrued to business owners and shareholders. And because business ownership and share-holding are concentrated among high-income households, the incidence of the program across the household income distribution was highly regressive… three-quarters of PPP benefits accrued to the top quintile of household income. By comparison, the incidence of federal pandemic unemployment insurance and household stimulus payments was far more equally distributed.

Note that this lack of targeting does not necessarily make PPP a bad program. Policymakers could have insisted on better targeting and provided stricter thresholds for getting the money. Doing so, however, likely would have substantially slowed down aid delivery and reduced program efficacy.

Some additional information:

  • Disbursement was rapid: $505 billion in first draw loans were issued and all but 7% were issued in 2020, most in April and May.
  • Business owners, not employees are primary beneficiaries. For the first 2 tranches of support 23%-34% of loans went to worker compensation; 66%-77% of loans went to business owners or creditors.
  • A regressive stimulus. Compared to unemployment insurance or the stimulus package, PPP was regressive in nature (see figure below).


Some may argue that PPP's regressive nature is highly problematic. All else equal, redistribution should favor the poor. However, if small and medium sized businesses were to go bankrupt, that would be detrimental to the economy not only in the short-run. If businesses dissolve, the know-how these businesses built up could disappear, as it is not easy to reconstitute a business once it has folded. Further, prices could rise due to a lack of competition if many small and medium sized businesses--perhaps with a less secure balance sheet--went under.

Program description

Businesses were permitted to draw PPP loans worth up to ten weeks of payroll costs—including wage and salary compensation not to exceed $100,000 per worker, as well as paid leave, health insurance costs, other benefit costs, and state and local taxes—with a maximum loan size of $10 million dollars.

While the moniker Paycheck Protection Program suggests that the program was focused solely on employment, the criteria for loan forgiveness reveal another complementary goal: providing firms with liquidity to meet non-compensation obligations to creditors (like suppliers, banks, and landlords). Businesses had to do four things to qualify for PPP loan forgiveness: 1) spend at least 60 percent of the loan amount on payroll expenses; 2) spend (at least) the full loan amount on total qualifying expenses, including payroll, utilities, rent, and mortgage payments; 3) maintain average full-time equivalent employment at its pre-crisis level; and 4) maintain employee wages at no lower than 75 percent of their pre- crisis level. 

Originally posted at Healthcare Economist

The views expressed herein are those of the author and not necessarily the views of FTI Consulting, Inc., its management, its subsidiaries, its affiliates, or its other professionals.

To view or add a comment, sign in

More articles by Jason Shafrin

  • When should we privatize government industries?

    When should we privatize government industries?

    Tyler Cowen is an economist from George Washington University and a libertarian. Thus, you would expect his answer to…

  • What is the PICOSI framework?

    What is the PICOSI framework?

    When conducting evidence synthesis, many individuals use the PICO framework. PICO stands for population; intervention;…

    1 Comment
  • My Publications in 2024

    My Publications in 2024

    Here is the list of my papers that were published in 2024. Manuscripts were published in Value in Health, BMJ Open…

    2 Comments
  • China's transition to DRG-based hospital reimbursement

    China's transition to DRG-based hospital reimbursement

    China has been transitioning from a fee-for-service (FFS) payment system to a Diagnosis-Related Group (DRG) payment…

  • How will AI change health care in 2025?

    How will AI change health care in 2025?

    To answer this question, I of course asked different AIs what the answer would be. Their responses: ChatGPT.

    1 Comment
  • Top 10 Healthcare Economist posts of 2024

    Top 10 Healthcare Economist posts of 2024

    What were the most popular posts on Healthcare Economist this year? Here are the top 10 in descending order: Valuing…

    3 Comments
  • Some good news: Opioid deaths on the decline...but why?

    Some good news: Opioid deaths on the decline...but why?

    In the US, opioid abuse has become and epidemic. However, in the past year, there is some hope that this epidemic is…

  • 2024 Books of the year

    2024 Books of the year

    Below are my favorite books of the year. These are my favorite books that I read this year, not necessarily books that…

  • Evolution of orphan drug

    Evolution of orphan drug

    A study by Fermaglich and Miller (2023) evaluated trends in orphan drug designations and approvals after the Orphan…

    1 Comment
  • Inequality in health outcomes in the US: Can we measure this?

    Inequality in health outcomes in the US: Can we measure this?

    A paper by Kowal et al. (2023) does in fact measure the disparities in health outcomes.

    1 Comment

Insights from the community

Others also viewed

Explore topics